According to Apollo Endosurgery's latest financial reports and stock price the company's current Operating Margin is -38.93%. At the end of 2021 the company had an Operating Margin of -38.94%.
Year | Operating Margin | Change |
---|---|---|
2021 | -38.94% | -27.13% |
2020 | -53.44% | -0.21% |
2019 | -53.55% | -28.53% |
2018 | -74.93% | 78.54% |
2017 | -41.97% | -33.25% |
2016 | -62.87% | -89.95% |
2015 | -625.74% | 92.03% |
2014 | -325.86% | 296.45% |
2013 | -82.19% | 99.73% |
2012 | -41.15% | 4.12% |
2011 | -39.52% | -31.01% |
2010 | -57.29% | -478.66% |
2009 | 15.13% | -103.69% |
2008 | -410.16% | -90.13% |
2007 | -4,156.30% | 268.97% |
2006 | -1,126.47% | 248.33% |
2005 | -323.39% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Merit Medical MMSI | 7.17% | -118.42% | ๐บ๐ธ USA |
Inari Medical
NARI | -2.74% | -92.96% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.